Which peptides are FDA-approved, and for what?Which peptides are FDA‑approved, and for what?
Every compound we cover, with its approved products, what each is approved for, and a link to the label. Compounded and research versions are marked plainly.Approved products, what each is approved for, and the label. Compounded and research versions marked plainly.
| Compound | Approved products and what they are approved for | Status | Label |
|---|---|---|---|
| Semaglutide | Wegovy (injection and tablet): chronic weight management; cardiovascular risk reduction; MASH with liver fibrosis Ozempic: type 2 diabetes Rybelsus: type 2 diabetes (tablet) | FDA-approved | Wegovy labelOzempic label |
| Tirzepatide | Zepbound: reducing and maintaining body weight; moderate to severe obstructive sleep apnea with obesity Mounjaro: type 2 diabetes; lowering the risk of major heart events in adults with type 2 diabetes | FDA-approved | Zepbound labelMounjaro label |
| Semaglutide or tirzepatide, compounded | Made by a pharmacy for one patient. Not reviewed by the FDA for safety, effectiveness or quality. | Compounded | No FDA label |
| Tesamorelin | Egrifta: reducing excess abdominal fat in adults with HIV and lipodystrophy | FDA-approved | Label |
| Bremelanotide | Vyleesi: acquired, generalized low sexual desire (HSDD) in premenopausal women | FDA-approved | Label |
| BPC-157 | No approved product. Studied mostly in animals. | Not approved for humans | None |
| GHK-Cu | No approved drug. Found in some cosmetic skin products, which are not drugs. | Not approved for humans | None |
| CJC-1295, ipamorelin | No approved product. | Not approved for humans | None |
Semaglutide
PrescriptionWegovy · weight management, heart risk, MASH
Ozempic, Rybelsus · type 2 diabetes
Tirzepatide
PrescriptionZepbound · weight management, sleep apnea
Mounjaro · type 2 diabetes, heart risk
Compounded versions
CompoundedMade by a pharmacy. Not FDA-approved or reviewed for safety.
Tesamorelin
PrescriptionEgrifta · abdominal fat in HIV lipodystrophy
Bremelanotide
PrescriptionVyleesi · low sexual desire, premenopausal women
BPC-157
Not approved for human useGHK-Cu, injected
Not approved for human useCJC-1295, ipamorelin
Not approved for human use
Checked against Drugs@FDA on November 14, 2026. Each name links to its label.
Checked against FDA approval records and each label on November 14, 2026. Approval is for the named product and use only.
What the three statuses meanWhat each status means
- FDA-approvedPrescription
- The FDA reviewed this exact product for this exact use. Approval does not carry over to other uses, other doses or copies.FDA-approved for the uses listed, by prescription. Other uses are off-label.
- CompoundedCompounded
- Made by a licensed pharmacy for an individual prescription. Legal in some situations, but not FDA-reviewed for safety, effectiveness or quality.Mixed by a pharmacy for one patient. Same ingredient, not the approved product.
- Not approvedNot approved for human use
- No approved product exists for people. Evidence is mostly from cell or animal studies. We explain the research; we never tell you where to get it.No approved product for people. Evidence is mostly from cell or animal studies.
Questions people ask
Is compounded semaglutide the same as Wegovy?
It may use the same active ingredient, but the product itself has not been reviewed by the FDA. Ask your pharmacist what form and strength you have.
Can a doctor prescribe something that is not approved?
Rules differ by product and state. This page reports approval status only; it is not legal advice.
How often is this table rechecked?
Whenever the FDA approves a product or changes a label for a compound we cover. The date under the table shows the last check.
Questions people ask
Is compounded semaglutide the same as Wegovy?
It may use the same active ingredient, but the product itself has not been reviewed by the FDA. Ask your pharmacist what form and strength you have.
Can a doctor prescribe something that is not approved?
Rules differ by product and state. This page reports approval status only; it is not legal advice.
How often is this table rechecked?
Whenever the FDA approves a product or changes a label for a compound we cover. The date under the table shows the last check.
Sources
1. U.S. Food and Drug Administration. Drugs@FDA approval records for each product listed. Checked November 14, 2026.
2. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. Checked November 14, 2026.
Last reviewed November 14, 2026 by the Linley Team.
Sources: Drugs@FDA; FDA statements on compounded GLP-1s. Last reviewed November 14, 2026.